Literature DB >> 21052894

Hepatic metastases from breast cancer.

Arianna Rubino1, Roberto Doci, Jean Claude Foteuh, Emanuela Morenghi, Susanna Fissi, Casimiro Giorgetta, Islam Abumalouh, Luca Di Tommaso, Leandro Gennari.   

Abstract

The prognosis of patients with hepatic metastasis from breast cancer treated with systemic or regional chemotherapy is disappointing. When technically feasible, liver resection offers the best results. Eighteen patients out of 22 submitted to laparotomy underwent radical liver resection. Median follow-up from liver resection was 36 months. The median time interval between breast cancer diagnosis and disease recurrence was 35 months. Median disease-free survival and overall survival from liver resection were 66 and 74 months, respectively. Median survival time from breast cancer surgery was 88.5 months. Surgical treatment of liver metastases should be carried out on young and older patients alike when site of metastases is the liver alone. Neoadjuvant treatment and preoperative diagnostic laparoscopy should be planned in future experience.

Entities:  

Mesh:

Year:  2010        PMID: 21052894     DOI: 10.1007/s13304-010-0026-7

Source DB:  PubMed          Journal:  Updates Surg        ISSN: 2038-131X


  30 in total

1.  Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis.

Authors:  E F Solomayer; I J Diel; G C Meyberg; C Gollan; G Bastert
Journal:  Breast Cancer Res Treat       Date:  2000-02       Impact factor: 4.872

2.  Surgical treatment of hepatic metastases from breast cancer.

Authors:  M Yoshimoto; T Tada; M Saito; K Takahashi; Y Uchida; F Kasumi
Journal:  Breast Cancer Res Treat       Date:  2000-01       Impact factor: 4.872

3.  The utility of estrogen receptor, progesterone receptor, and Her-2/neu status to predict survival in patients undergoing hepatic resection for breast cancer metastases.

Authors:  Steve R Martinez; Shawn E Young; Armando E Giuliano; Anton J Bilchik
Journal:  Am J Surg       Date:  2006-02       Impact factor: 2.565

Review 4.  Young age and outcome for women with early-stage invasive breast carcinoma.

Authors:  Ping Zhou; Abram Recht
Journal:  Cancer       Date:  2004-09-15       Impact factor: 6.860

5.  Prognostic relevance of proliferative activity evaluated by Mib-1 immunostaining in node negative breast cancer.

Authors:  A Neri; D Marrelli; C Pedrazzani; S Caruso; A De Stefano; F Mariani; T Megha; G De Marco; G Corso; E Pinto; F Roviello
Journal:  Eur J Surg Oncol       Date:  2008-03-04       Impact factor: 4.424

Review 6.  An attempt to clarify indications for hepatectomy for liver metastases from breast cancer.

Authors:  Dominique Elias; Franck Maisonnette; Michel Druet-Cabanac; Jean Francois Ouellet; Jean Marc Guinebretiere; Marc Spielmann; Suzette Delaloge
Journal:  Am J Surg       Date:  2003-02       Impact factor: 2.565

7.  R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery?

Authors:  Robbert J de Haas; Dennis A Wicherts; Eduardo Flores; Daniel Azoulay; Denis Castaing; René Adam
Journal:  Ann Surg       Date:  2008-10       Impact factor: 12.969

8.  The role of human epidermal growth factor receptor 2 in the survival of women with estrogen and progesterone receptor-negative, invasive breast cancer: the California Cancer Registry, 1999-2004.

Authors:  Monica Brown; Alex Tsodikov; Katrina R Bauer; Carol A Parise; Vincent Caggiano
Journal:  Cancer       Date:  2008-02-15       Impact factor: 6.860

9.  Cancer statistics, 1995.

Authors:  P A Wingo; T Tong; S Bolden
Journal:  CA Cancer J Clin       Date:  1995 Jan-Feb       Impact factor: 508.702

10.  Her-2/neu gene amplification and response to paclitaxel in patients with metastatic breast cancer.

Authors:  Gottfried E Konecny; Christoph Thomssen; Hans Joachim Lück; Michael Untch; He-Jing Wang; Walter Kuhn; Holger Eidtmann; Andreas du Bois; Sigrid Olbricht; Dieter Steinfeld; Volker Möbus; Gunter von Minckwitz; Suganda Dandekar; Lillian Ramos; Giovanni Pauletti; Mark D Pegram; Fritz Jänicke; Dennis J Slamon
Journal:  J Natl Cancer Inst       Date:  2004-08-04       Impact factor: 13.506

View more
  6 in total

Review 1.  Appraisal of Laparoscopic Liver Resection in the Treatment of Liver Metastasis with Special Reference to Outcome in Colorectal Malignancies.

Authors:  Priya Hazrah; Deborshi Sharma; Saurabh Borgharia; Pawan Kumar; Romesh Lal
Journal:  Indian J Surg       Date:  2013-07-25       Impact factor: 0.656

2.  Cataclysmic Gastrointestinal Hemorrhage: Dreaded Complication of Metastatic Breast Cancer.

Authors:  Hanane Delsa; Sara Mounsif; Najwa Benslima; Mohamed Mahi; Fedoua Rouibaa
Journal:  Cureus       Date:  2022-05-19

Review 3.  Surgical Management of Metastatic Breast Cancer: A Mini Review.

Authors:  Takayuki Ueno
Journal:  Front Oncol       Date:  2022-05-04       Impact factor: 5.738

4.  Aggressive treatment for hepatic metastases from breast cancer: results from a single center.

Authors:  F Polistina; G Costantin; A Febbraro; E Robusto; G Ambrosino
Journal:  World J Surg       Date:  2013-06       Impact factor: 3.352

5.  Stereotactic Radiofrequency Ablation of Breast Cancer Liver Metastases: Short- and Long-Term Results with Predicting Factors for Survival.

Authors:  Peter Schullian; Edward Johnston; Gregor Laimer; Daniel Putzer; Gernot Eberle; Yannick Scharrl; Claudia Ianetti-Hackl; Reto Bale
Journal:  Cardiovasc Intervent Radiol       Date:  2021-04-06       Impact factor: 2.740

6.  Long-term survival and cure model following liver resection for breast cancer metastases.

Authors:  Aldrick Ruiz; Mylène Sebagh; Dennis A Wicherts; Carlos Castro-Benitez; Richard van Hillegersberg; Bernard Paule; Denis Castaing; Eric Vibert; Antonio Sa Cunha; Daniel Cherqui; Jean-François Morère; René Adam
Journal:  Breast Cancer Res Treat       Date:  2018-02-20       Impact factor: 4.872

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.